Journal
ACTA PSYCHIATRICA SCANDINAVICA
Volume 119, Issue 4, Pages 252-265Publisher
WILEY
DOI: 10.1111/j.1600-0447.2008.01326.x
Keywords
mild cognitive impairment; dementia; risk; Alzheimer's disease; meta-analysis
Categories
Ask authors/readers for more resources
To quantify the risk of developing dementia in those with mild cognitive impairment (MCI). Meta-analysis of inception cohort studies. Forty-one robust cohort studies were identified. To avoid heterogeneity clinical studies, population studies and clinical trials were analysed separately. Using Mayo defined MCI at baseline and adjusting for sample size, the cumulative proportion who progressed to dementia, to Alzheimer's disease (AD) and to vascular dementia (VaD) was 39.2%, 33.6% and 6.2%, respectively in specialist settings and 21.9%, 28.9% and 5.2%, respectively in population studies. The adjusted annual conversion rate (ACR) from Mayo defined MCI to dementia, AD and VaD was 9.6%, 8.1% and 1.9%, respectively in specialist clinical settings and 4.9%, 6.8% and 1.6% in community studies. Figures from non-Mayo defined MCI and clinical trials are also reported. The ACR is approximately 5-10% and most people with MCI will not progress to dementia even after 10 years of follow-up.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available